Radiofrequency catheter ablation of supraventricular tachycardia in children and adolescents: Feasibility and cost-effectiveness in a low-income country

Pediatric Cardiology

Volumn 27, Issue 4, 2006, Pages 434-439

  Vida, Vladimiro L ^a   Calvimontes, Gonzalo S ^a   Macs, Maximo O ^a   Aparicio, Patricia ^a   Barnoya, Joaquin ^a   Castañeda, Aldo R ^a  

^a UNICAR   (Guatemala)

Author keywords

Cost effectiveness; Radiofrequency ablation; Supraventricular tachycadia

Indexed keywords

ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GUATEMALA; HUMAN; LOWEST INCOME GROUP; MALE; PATIENT SAFETY; SCHOOL CHILD; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; CHILD; COST-BENEFIT ANALYSIS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GUATEMALA; HUMANS; MALE; REOPERATION; RETROSPECTIVE STUDIES; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 33747134135     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-006-1220-8     Document Type: Article

References (32)

1. Bathina MN, Mickelsen S, Brooks C, et al. (1998) Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 82:589-593
2. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. (2003) European Society of Cardiology Committee, NASPE-Heart Rhythm Society. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 42:1493-1531
3. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. (2003) American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines, Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias). Circulation 108:1871-1909
4. Cheng CHF, Gillian DS, Hlatky MA, et al. (2000) Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med 133:864-876
5. Chetaille P, Walsh EP, Triedman JK (2004) Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm 1:168-173
6. Chun TU, Van Hare GF (2004) Advances in the approach to treatment of spraventricular tachycardia in the pediatric population. Curr Cardiol Rep 6:322-326
7. de Buitleir M, Sousa J, Bolling SF, et al. (1991) Reduction in medical care cost associated with radiofrequency catheter ablation of accessory pathways. Am J Cardiol 68:1656-1661
8. Garson A Jr, Kanter RJ (1997) Management of the child with Wolff-Parkinson-White syndrome and Supraventricular tachycardia: model for cost effectiveness. J Cardiovasc Electrophysiol 8:1320-1326
9. Gillette PC (1985) Supraventricular arrhythmias in children. J Am Coll Cardiol 5:122B-129B
10. Glantz S (2002) Primer of Biostatistics, 5th edn. McGraw-Hill, New York
11. Hogenhuis W, Stevens SK, Wang P, et al. (1993) Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome. Circulation 88:437-446
12. Ikeda T, Sugi K, Enjoji Y, et al. (1994) Cost effectiveness of radiofrequency catheter ablation versus medical treatment for paroxysmal supraventricular tachycardia in Japan. J Cardiol 24:461-468
13. Iturralde P, Colin L, Kershenovich S, et al. (2000) Radiofrequency catheter ablation for the treatment of Supraventricular tachycardias in children and adolescents. Cardiol Young 10:376-383
14. Kafali G, Celiker A, Ozer S (2003) Successful radiofrequency catheter ablation therapy of an adolescent with atrial ectopic tachycardia: Turk J Pediatr 45:342-344
15. Kalbfleisch SJ, Calkins H, Langberg JJ, et al. (1992) Comparison of cost of radiofrequency catheter modification of the atrioventricular nose and medical therapy for drug-refractory atrioventricular node reentrant tachycardia. J Am Coll Cardiol 19:1583-1587
16. Kammeraad J, ten Cate FU, Simmers T, et al. (2004) Radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in children aided by the LocaLisa mapping system. Europace 6:209-214
17. Kertes PJ, Kalman JM, Tonkin AM (1993) Cost effectiveness of radiofrequency catheter ablation in the treatment of symptomatic supraventricular tachyarrhythmias. Aust NZ J Med 23:433-436
18. Ko JK, Ban JE, Kim YH, Park IS (2004) Long-term efficacy of atenolol for atrioventricular reciprocating tachycardia in children less than 5 years old. Pediatr Cardiol 25:97-101
19. Kugler JD, Danford DA, Deal BJ, et al. (1994) Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med 330:1481-1487
20. Kugler JD, Danford DA, Houston K, Felix G (1997) Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol 80:1438-1443
21. Lee SJ, Schueller WC (2000) Tachycardias in infants, children and adolescents: safety and effectiveness of radiofrequency catheter ablation. Cardiology 94:44-51
22. Lesh MD, Van Hare GF, Schamp DJ, et al. (1992) Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients. J Am Coll Cardiol 19:1303-1309
23. Pappone C, Manguso F, Santinelli R, et al. (2004) Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med 351:1197-1205
24. Pfammatter JP, Weber JW, Stocker FP (1998) Atenolol for preventing recurrence of atrioventricular reentry tachycardia in childhood. Klin Padiatr 210:358-362
25. Reiffel JA (2001) Issues in the use of generic antiarrhythmic drugs. Curr Opin Cardiol 16:23-29
26. Sacchetti A, Moyer V, Baricella R, Cameron J, Moakes ME (1999) Primary cardiac arrhythmias in children. Pediatr Emerg Care 15:95-98
27. Schluter M, Geiger M, Siebels J, Duckeck W, Kuck KH (1991) Catheter ablation using radiofrequency current to cure symptomatic patients with tachyarrhythmias related to an accessory atrioventricular pathway. Circulation 84:1644-1661
28. Transition System, Inc. (1988) Product Line Manager: Sample Reports. Transition System, Inc., Boston
29. Van Hare GF, Javitz H, Carmelli D, et al. (2004) Participating members of the Pediatric Electrophysiology Society. Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia. Heart Rhythm 1:188-196
30. Van Hare GF, Velvis H, Langberg JJ (1990) Successful transcatheter ablation of congenital junctional ectopic tachycardia in a ten-month-old infant using radiofrequency energy. Pacing Clin Electrophysiol 13:730-735
31. Wang L, Li J, Yao R, Song S (2004) Simplified approach to radiofrequency catheter ablation of paroxysmal supraventricular tachycardia. Croat Med J 45:167-170
32. Weerasooriya HR, Murdock CJ, Harris AH, Davis MJ (1994) The cost-effectiveness of treatment of supraventricular arrhythmias related to an accessory atrioventricular pathway; comparison of catheter ablation, surgical division and medical treatment. Aust NZ J Med 24:161-167